4 Best Stocks That Could Be a Blast (BAC, AAPL, PPHM, FB)

Los Angelas, CA -- (SBWIRE) -- 11/01/2012 -- Bank of America Corporation (NYSE:BAC) is one of the world's largest financial institutions, serving individual consumers, small- and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 55 million consumer and small business relationships with approximately 5,500 banking centers and approximately 16,300 ATMs and award-winning online banking with 30 million active online banking users. In the last trading session, shares of Bank of America Corporation ended higher by 2.19% to US$9.32 on over 94.90 million shares, compared to its average volume of 140.99 million shares. In the past 52 weeks, Bank of America share prices have been bracketed by a low of US$4.92 and a high of US$10.10, and is now at US$9.32 (89% above that low price).

Can BAC Extend Gain? If Yes, How Far It Can Go? Find Out Here

Apple Inc. (NASDAQ:AAPL) reported its financial results third calendar quarter and fourth fiscal quarter of 2012. AAPL reported a net quarterly profit of $8.2 billion on $36.0 billion in revenue, which comes out to roughly $8.67 per diluted share. During the fourth fiscal quarter of 2011, Apple reported $28.27 billion in revenue with a net quarterly profit of $6.62 billion, coming out to about $7.05 per diluted share. With each passing year, Apple has posted a higher quarterly revenue and profit, increasing its per share price by almost $1.67 per share since this time last year. With improvements in each quarter, Apple has set a record revenue for for fiscal 2012, reporting a total revenue of $156.5 billion with a net profit of $41.7 billion. Revenue and profit for fiscal 2012 comes in much higher than 2011, which brought in $108.2 billion in sales and $25.9 billion in profit. Apple expects revenue for the first quarter of fiscal 2013 to be yet another record with expected revenue of $52 billion and earnings per diluted share of $11.75. Apple has yet to include holiday sales for this year, which will likely be much higher than fiscal 2011, as Apple introduced an entirely new lineup of iPods, the new iPhone 5, as well as the iPad mini which is expected to be a major success this holiday.

Can AAPL Continue To Move Higher? Find out Here

Facebook Inc. (NASDAQ:FB) decided to make an expansive move in its revenue net. According to recent news reports, the world’s biggest online social networking site is poised to launch a new ad campaign called the “fast track,” extending its already launched classified ads. The idea is simple, charge people for the placement of their ads, specifically relating to their own needs. The ads may be like “roommate-wanted” posted by individuals. The service may extend to small companies searching for new employees as well. Facebook Inc (FB)’s existing tools are already serving several small enterprises to place ads to find the desired human resources. The recent offer resembles controversial service Facebook Inc (NASDAQ:FB) recently launched where individuals are charged for boosting the visibility of their posts.

Will FB Stable This Top Position? Find Out Here

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. Peregrine Pharmaceuticals, Inc. is -0.0474 - -5.45% from the previous close of $0.87. It traded between $0.8005 - 0.87 with total traded volume of 2297162 shares. Keep a close eye on PPHM, as the stock has been showing unusual moves over the past weeks. At Current market price, PPHM has recovered +110.92% from its 52-week Low of 0.39 and has Pulled back -85.04% from its 52-week high of 5.50. Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) declined 3.33% to $0.841 on a traded volume of 1.37 million shares.The Company announced the presentation of preclinical data showing specific localization and enhancement of anti-tumor functions of immune cells inside tumors following administration of Phosphatidylserine -targeting antibodies.

Can PPHM Extend Rally? Find Out Here

DISCLAIMER:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com